期刊文献+

慢性脑低灌注性血管性认知损害患者血清p75神经营养素受体细胞外段水平及其与炎性因子的关系

Serum p75 neurotrophin receptor-extracellular domain level and its relationship with inflammatory factors in patients with chronic cerebral hypoperfusion-vascular cognitive impairment
下载PDF
导出
摘要 目的检测慢性脑低灌注性血管性认知损害(CCH-VCI)患者血清p75神经营养素受体细胞外段(p75NTR-ECD)水平,并探讨其与肿瘤坏死因子α(TNF-α)、白细胞介素(IL)-1β、IL-6的关系。方法选择海军军医大学(第二军医大学)长海医院2018年8月至12月收治的34例CCH-VCI患者,以及同期相同年龄段的36名中老年健康人和34例缺血性脑卒中患者作为研究对象。采用酶联免疫吸附试验测定3组研究对象的血清p75NTR-ECD、TNF-α、IL-1β、IL-6水平并进行组间比较。采用Spearman相关分析研究CCH-VCI患者血清p75NTR-ECD水平与TNF-α、IL-1β、IL-6水平的相关性。结果CCH-VCI组血清p75NTR-ECD水平高于健康对照组和缺血性脑卒中组[(544.36(440.88,628.50)pg/mL vs 276.49(262.59,313.87)pg/mL、366.87(337.09,450.43)pg/mL],差异均有统计学意义(U=87.500、335.500,P均<0.05)。CCH-VCI组患者血清TNF-α、IL-1β、IL-6水平分别为196.02(141.20,280.35)pg/mL、68.23(60.79,91.94)pg/mL、51.04(40.24,65.26)pg/mL,缺血性脑卒中组分别为218.67(143.76,281.28)pg/mL、76.87(59.10,99.91)pg/mL、64.45(43.13,86.76)pg/mL,均分别高于健康对照组[分别为73.71(56.94,79.81)pg/mL、42.98(34.52,51.34)pg/mL、14.97(11.76,21.19)pg/mL],差异均有统计学意义(U=31.000、4.000,106.000、132.000,48.000、13.000;P均<0.05)。CCH-VCI患者血清p75NTR-ECD水平与TNF-α水平存在相关性(r=0.391,P=0.022),但与IL-1β和IL-6水平均无明显相关性(r=0.032、0.164,P=0.855、0.355)。结论慢性脑低灌注损伤后p75NTR可能与TNF-α等炎性因子有关,并共同参与了CCH-VCI的发病。 Objective To investigate serum p75 neurotrophin receptor-extracellular domain(p75NTR-ECD)level in patients with chronic cerebral hypoperfusion-vascular cognitive impairment(CCH-VCI)and its relationship with tumor necrosis factorα(TNF-α),interleukin(IL)-1βand IL-6.Methods The clinical data of patients with CCH-VCI(n=34)were collected from Changhai Hospital,Naval Medical University(Second Military Medical University)from Aug.to Dec.2018.Enzyme linked immunosorbent assay was applied for detection of serum levels of p75NTR-ECD,TNF-α,IL-1βand IL-6;and the results were then compared with those of ischemic stroke participants(n=34)and healthy controls(n=36),who were all in the same age range.Spearman correlation analysis was used to analyze the relationship between serum p75NTR-ECD level and the above-mentioned inflammatory factors in CCH-VCI patients.Results The serum p75NTR-ECD level in the CCHVCI group was significantly higher than those in the healthy control group and the ischemic stroke group(544.36[440.88,628.50]pg/mL vs 276.49[262.59,313.87]pg/mL and 366.87[337.09,450.43]pg/mL,U=87.500 and 335.500,both P<0.05).The serum levels of TNF-α,IL-1βand IL-6 were 196.02(141.20,280.35)pg/mL,68.23(60.79,91.94)pg/mL and 51.04(40.24,65.26)pg/mL in the CCH-VCI group,respectively,and 218.67(143.76,281.28)pg/mL,76.87(59.10,99.91)pg/mL and 64.45(43.13,86.76)pg/mL in the ischemic stroke group,respectively,which were all significantly higher than those in the healthy control group(73.71[56.94,79.81]pg/mL,42.98[34.52,51.34]pg/mL and 14.97[11.76,21.19]pg/mL,respectively;U=31.000 and 4.000,106.000 and 132.000,and 48.000 and 13.000;all P<0.05).Serum p75NTR-ECD level in the CCH-VCI patients was correlated with TNF-αlevel(r=0.391,P=0.022),but not with IL-1βor IL-6 levels(r=0.032 and 0.164,P=0.855 and 0.355).Conclusion Serum p75NTR level may be related to inflammatory factors(TNF-α)after chronic cerebral hypoperfusion,and they may jointly participate in the pathogenesis of CCH-VCI.
作者 陈甲 秦鲁平 罗猛 赵明 陈蕾 吴涛 邓本强 CHEN Jia;QIN Lu-ping;LUO Meng;ZHAO Ming;CHEN Lei;WU Tao;DENG Ben-qiang(Stroke Center,Changhai Hospital,Naval Medical University (Second Military Medical University),Shanghai 200433,China)
出处 《第二军医大学学报》 CAS CSCD 北大核心 2019年第6期602-607,共6页 Academic Journal of Second Military Medical University
基金 上海市科委医学引导类项目(124119a8900)~~
关键词 脑低灌注 血管性认知损害 p75神经营养素受体细胞外段 炎性因子 cerebral hypoperfusion vascular cognitive impairment p75 neurotrophin receptor-extracellular domain inflammatory factor
  • 相关文献

参考文献1

二级参考文献79

  • 1郭起浩,洪震,史伟雄,孙一忞,吕传真.Boston命名测验在识别轻度认知损害和阿尔茨海默病中的作用[J].中国心理卫生杂志,2006,20(2):81-84. 被引量:54
  • 2陆骏超,郭起浩,洪震,史伟雄,吕传真.连线测验(中文修订版)在早期识别阿尔茨海默病中的作用[J].中国临床心理学杂志,2006,14(2):118-120. 被引量:128
  • 3Bowler JV,Hachinski V. Vascular cognitive impairment : a new approach to vascular dementia[J]. Baillieres Clin Neurol, 1995 ,4(2):357-376.
  • 4Gorelick PB, Scuteri A, Black SE,et al. Vascular contributions to cognitive impairment and dementia : a statement for healthcare professionals from the american heart association/american stroke association[J]. Stroke,2011,42(9):2672-2713.
  • 5O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment[J]. Lancet Neurol,2003 ,2(2):89-98.
  • 6Sachdev P,Kalaria R, Or Brien J, et al. Diagnostic criteria for vascular cognitive disorders : a VASCOG statement[J]. Alzheimer Dis Assoc Disord,2014,28(3):206-218.
  • 7Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population[J]. Lancet, 1997 ,349(9068):1793-1796.
  • 8Hachinski V,Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards[J]. Stroke,2006, 37(9):2220-2241.
  • 9Sachdev PS, Blacker D, Blazer DG,et al. Classifying neurocognitive disorders : the DSM 5 approach[J]. Nat Rev Neurol, 2014,10(11):634-642.
  • 10Albert MS,DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease : recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease[J]. Alzheimers Dement, 2011,7(3):270-279.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部